Precision Genomics.
Actionable Insights.
Transforming genomic and biological data into actionable insights for improved patient outcomes in healthcare and life sciences.


Learn about our commitment to genomics excellence.

Why Choose AccuraGenolytics for Your Solutions?
AccuraGenolytics Private Limited is a leader in precision genomics, promoting advancements in bioinformatics for healthcare and biotechnology through innovative data analysis and solutions.
Comprehensive Genomics and Bioinformatics Solutions
01.
Next-Generation Sequencing (NGS) Analysis
End-to-end processing of high-throughput sequencing data. We provide customized pipelines for RNA-Seq, Whole Exome Sequencing (WES), and targeted panels, transforming raw .fastq files into publication-ready figures and structured data matrices.

02.
Clinical Variant Interpretation
Evidence-based genomic variant classification aligned with strict ACMG/AMP guidelines. We cross-reference datasets against established biomedical databases to evaluate clinical significance, pathogenic potential, and actionable therapeutic targets.

03.
Bioinformatics Infrastructure
Robust bioinformatics solutions tailored to your needs.

Join Us in Revolutionizing Healthcare
Discover how our genomic analytics solutions can enhance your research and precision medicine initiatives today.
Our Unique Advantages
Precision Insights
Delivering tailored, actionable genomic insights for personalized medicine and research outcomes in diverse healthcare applications.
Data Integrity
Ensuring high-quality, compliant data management that meets global standards like HIPAA and GDPR for secure genomic analysis.
Innovative Solutions
Utilizing cutting-edge technologies in AI and computational genomics for advanced data interpretation and healthcare advancements.


What Our Clients Say


Our Recent Projects and Achievements






Research & Development (R&D)
Computational genomics and high-throughput multi-omics services built to accelerate scientific discovery for academic institutes, universities, and biotech enterprises.
- Core Capabilities:
- Agricultural & Animal Genomics: Custom sequencing, genotyping, and variant discovery to accelerate trait selection and evolutionary biology research.
- Plant Genomics & Breeding Solutions: Advanced transcriptomic and genomic profiling to support crop resilience, genetic mapping, and agricultural innovation.
- Metagenomics & Environmental Sequencing: Taxonomic profiling and functional characterization of complex microbial communities from diverse ecosystems.
- Transcriptomics & Expression Profiling: Comprehensive RNA-Seq workflows, differential gene expression metrics, and pathway analysis.
- End-to-End Computational Genomics: Seamless pipelines converting raw sequencing files into publication-ready figures, data matrices, and biological insights.
- Institutional Collaborations: Dedicated frameworks for joint research initiatives, grant-backed studies, and co-development projects with global universities. [1, 2, 3]
Clinical Genomics & Diagnostics
- High-precision clinical variant workflows, screening panels, and multi-omics profiling designed to support diagnostic decision-making, patient monitoring, and preventive medicine.
- Core Capabilities (Bullet Points):
- Whole Exome Sequencing (WES): High-depth exon capture and variant filtering for rare disease identification and complex clinical phenotypes.
- Targeted Diagnostics & Oncology Panels: Comprehensive genomic profiling of somatic and germline mutations to guide targeted oncology therapeutics.
- Non-Invasive Prenatal Testing (NIPT): Advanced cell-free DNA (cfDNA) analysis workflows providing highly accurate screens for fetal aneuploidies.
- ACMG/AMP Variant Interpretation: Evidence-based clinical reporting and pathogenicity grading using definitive global standards and health databases.
- Reproductive & Preventive Screening: Carrier and premarital screening workflows designed to detect inherited genetic variations and risk profiles.
- Personalised Microbiome Diagnostics: High-resolution sequencing of gut and vaginal microbiomes to map metabolic wellness and dysbiosis.
- Pharmacogenomics (PGx): Genetic analysis of drug-metabolising enzymes to optimize therapeutic drug selection and avoid adverse events. [1, 2, 3, 4, 5]
